Skip to content

MDMA: all studies

Page 58 of 345: studies 571 to 580 of 3,446, newest first. Back to the MDMA overview

Research

Use characteristics and harm potential of ecstasy in The Netherlands

Drugs Education Prevention and Policy September 10, 2020 Jan Van Amsterdam, Johannes G. Ramaekers, Ton Nabben et al. 4 citations

Introduction Ecstasy (MDMA) is a popular recreational drug, but its illegal production and trade in the Netherlands have developed into a serious public order and ecological problem which endanger and question the harm reduction approach of the Dutch ecstasy policy.Methods The market characteristics, adverse health effects, risk profile, and link to criminal activity of ecstasy were...

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice

Neuropsychopharmacology Reports September 1, 2020 Satoko Mukai, Sao Nakada, Hikari Kamada et al.

AbstractA recreational drug, 3,4‐methylenedioxymethamphetamine (MDMA), has prosocial effects including increased sociability, enhancement of trust feelings, and empathy. Although several methods, such as the social interaction and three chamber tests, have been used, the neural mechanisms underlying the prosocial effects have not been well understood. In the present study, based on a social...

Regional changes in ∆FosB expression in rat brain following MDMA self‐administration predict increased sensitivity to effects of locally infused MDMA

Addiction Biology September 1, 2020 Ross Van de Wetering, Susan Schenk 9 citations

AbstractRepeated exposure to drugs produces a plethora of persistent brain changes, some of which underlie the development of drug addiction. An important objective of addiction research is to identify the brain changes that might mediate the transition from drug use to drug misuse. The persistent accumulation of the transcription factor, ∆FosB, following repeated drug exposure provides a means...

Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.

Substance Abuse Treatment, Prevention, and Policy August 5, 2020 Madeleine Southey, Ashwini Kathirgamalingam, Benjamin Crawford et al.

Pill testing services could potentially be used to reduce drug-related harm. This study aims to identify patterns of ecstasy use among live music event attendees; explore the opinions and potential usage of illicit pill testing programs and examine factors associated with the likelihood of still taking a pill containing a potential harmful substance. A cross-sectional survey was completed by...

The impact of 3,4-methylendioxymetamphetamine (MDMA) abstinence on seeking behavior and the expression of the D2-like and mGlu5 receptors in the rat brain using saturation binding analyses.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society August 2020 Małgorzata Frankowska, Joanna Miszkiel, Lucyna Pomierny-Chamioło et al.

The abundance of research indicates that enriched environment acts as a beneficial factor reducing the risks of relapse in substance use disorder. There is also strong evidence showing the engagement of brain dopaminergic and glutamatergic signaling through the dopamine D2-like and metabotropic glutamate type 5 (mGlu5) receptors, respectively, that has a direct impact on drug reward and drug...

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Psychopharmacology August 1, 2020 Lisa Jerome, Allison A. Feduccia, Julie B. Wang et al. 163 citations Retracted

Posttraumatic stress disorder (PTSD) is a chronic condition that has wide-ranging negative effects on an individual's health and interpersonal relationships. Treatments with long-term benefits are needed to promote the safety and well-being of those suffering from PTSD. To examine long-term change in PTSD symptoms and additional benefits/harms after 3,4-methylenedioxymethamphetamine...

Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans

Metabolites July 27, 2020 Andrea E. Steuer, Daria Kaelin, Martina I. Boxler et al. 32 citations

Psychoactive stimulants are a popular drug class which are used recreationally. Over the last decade, large numbers of new psychoactive substances (NPS) have entered the drug market and these pose a worldwide problem to human health. Metabolomics approaches are useful tools for simultaneous detection of endogenous metabolites affected by drug use. They allow identification of pathways or...

Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.

Behavioural Brain Research July 9, 2020 Tomohisa Mori, Naoki Uzawa, Daiki Masukawa et al.

Orexinergic neurons, which are closely associated with narcolepsy, regulate arousal and reward circuits through the activation of monoaminergic neurons. Psychostimulants as well as 5-HT-related compounds have potential in the treatment of human narcolepsy. Previous studies have demonstrated that orexin receptor antagonists as well as orexin deficiencies affect the pharmacological effects of...

Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats

Journal of Psychopharmacology July 1, 2020 Michael B. Gatch, Michael J Forster

Background: Synthetic cathinone derivatives are used as alternatives both for stimulant drugs such as cocaine and methamphetamine and for club drugs such as 3,4-methylenedioxymethamphetamine (MDMA), but little is known about their MDMA-like subjective effects. Methods In order to determine their similarity to MDMA, the discriminative stimulus effects of 10 pyrrolidinyl cathinones...

A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity.

International Journal of Neuroscience July 2020 G D Searchfield, T N E R Poppe, M Durai et al.

Background: This study was conducted to investigate the short-term behavioural and neurophysiological effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus perception.Methods: A double-blind randomized controlled cross-over design. Part 1. Behavioural measures of tinnitus following 30 mg MDMA or placebo administration (N = 5 participants) and Part 2. Behavioural measures of tinnitus...

DOI: 10.1080/00207454.2019.1702544 (opens in new tab) Full text (opens in new tab) 3,4-methylenedioxymethamphetamine Tinnitus Rs-MRI Treatment